We also showed that GATA4’s secretome was necessary for its tumor-suppressive effect by identifying the GATA4-induced secreted factor CCL2 and demonstrate that CCL2 was partially responsible for GATA4’s tumor-suppressive effects in vivo using a CCL2-targeting antibody. This evidence concerns the gene CCL2 and neoplasm.